SCHOTT Pharma

Update in progress

1SXP.DE (XETRA)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Schott Pharma AG & Co. KGaA develops, manufactures, and sells drug containment and delivery systems for injectable drugs worldwide. It offers glass syringes (syriQ, syriQ BioPure, silicone-free) and polymer syringes (TOPPAC), plus cartridges, vials, and ampoules (cartriQ, EVERIC, adaptiQ, easyOPC, anti-counterfeiting). The company provides containment, analytics, fill‑finish, regulatory, and sustainability services. Founded 1884, Mainz, Germany; subsidiary of Schott.

Company score

Sentiment: 0.44; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.10; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.28; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.28; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive